000 01267 a2200361 4500
005 20250518091516.0
264 0 _c20201222
008 202012s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/s41416-020-0770-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChisholm, Julia C
245 0 0 _aTumour-agnostic drugs in paediatric cancers.
_h[electronic resource]
260 _bBritish journal of cancer
_c05 2020
300 _a1425-1427 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aDrug Approval
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aOncogene Proteins, Fusion
_xdrug effects
650 0 4 _aPediatrics
650 0 4 _aPharmaceutical Preparations
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aPyrazoles
_xtherapeutic use
650 0 4 _aPyrimidines
_xtherapeutic use
700 1 _aCarceller, Fernando
700 1 _aMarshall, Lynley V
773 0 _tBritish journal of cancer
_gvol. 122
_gno. 10
_gp. 1425-1427
856 4 0 _uhttps://doi.org/10.1038/s41416-020-0770-5
_zAvailable from publisher's website
999 _c30731757
_d30731757